US equities
|
GOOGL
$283.82
▼-12.64%
GOOG
$281.73
▼-12.48%
MSFT
$530.14
▼-0.16%
META
$624.52
▲+1.96%
MU
$934.27
▼-4.98%
AMZN
$243.79
▼-4.25%
NVDA
$213.60
▼-0.83%
AAPL
$348.91
▲+1.48%
GOOGL
$283.82
▼-12.64%
GOOG
$281.73
▼-12.48%
MSFT
$530.14
▼-0.16%
META
$624.52
▲+1.96%
MU
$934.27
▼-4.98%
AMZN
$243.79
▼-4.25%
NVDA
$213.60
▼-0.83%
AAPL
$348.91
▲+1.48%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about lupus nephritis
Recent news which mentions lupus nephritis
Aurinia's Voclosporin Shows favorable Risk/Benefit Profile Over 3 Years In Lupus Nephritis
December 09, 2021
Tickers
AUPH
Tags
Phase 3 Trial
lupus nephritis
Health Care
From
Benzinga